Literature DB >> 32658298

Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial.

J Todd Arnedt1, Deirdre A Conroy1, Ann Mooney1, Allison Furgal2,3, Ananda Sen2,3, Daniel Eisenberg4.   

Abstract

STUDY
OBJECTIVES: In a randomized controlled noninferiority trial, we compared face-to-face and telemedicine delivery (via the AASM SleepTM platform) of cognitive-behavioral therapy (CBT) for insomnia for improving insomnia/sleep and daytime functioning at posttreatment and 3-month follow-up. A secondary objective compared the modalities on treatment credibility, satisfaction, and therapeutic alliance.
METHODS: A total of 65 adults with chronic insomnia (46 women, 47.2 ± 16.3 years of age) were randomized to 6 sessions of CBT for insomnia delivered individually via AASM SleepTM (n = 33, CBT-TM) or face-to-face (n = 32, CBT-F2F). Participants completed sleep diaries, the Insomnia Severity Index (ISI), and daytime functioning measures at pretreatment, posttreatment, and 3-month follow-up. Treatment credibility, satisfaction, and therapeutic alliance were compared between treatment modalities. The ISI was the primary noninferiority outcome.
RESULTS: Based on a noninferiority margin of four points on the ISI and, after adjusting for confounders, CBT-TM was noninferior to CBT-F2F at posttreatment (β = 0.54, SE = 1.10, 95% CI = 1.64 to 2.72) and follow-up (β = 0.34, SE = 1.10, 95% CI = 1.83 to 2.53). Daytime functioning measures, except the physical composite scale of the SF-12, were significantly improved at posttreatment and follow-up, with no difference between treatment formats. CBT-TM sessions were, on average, nearly 10 min shorter, yet participant ratings of therapeutic alliance were similar to CBT-F2F.
CONCLUSIONS: Telemedicine delivery of CBT for insomnia is not inferior to face-to-face for insomnia severity and yields similar improvements on other sleep and daytime functioning outcomes. Further, telemedicine allows for more efficient treatment delivery while not compromising therapeutic alliance. CLINICAL TRIAL REGISTRATION NUMBER: NCT03293745. © Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  face-to-face; insomnia; noninferiority trial; telemedicine

Year:  2021        PMID: 32658298     DOI: 10.1093/sleep/zsaa136

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  10 in total

1.  The Survivorship Sleep Program (SSP): A synchronous, virtual cognitive behavioral therapy for insomnia pilot program among cancer survivors.

Authors:  Daniel L Hall; Kimberly A Arditte Hall; Mark J Gorman; Amy Comander; Michael R Goldstein; Tony J Cunningham; Sarah Wieman; Helen R Mizrach; Brooke C Juhel; Raissa Li; Alexandros Markowitz; Michael Grandner; Elyse R Park
Journal:  Cancer       Date:  2021-12-16       Impact factor: 6.860

2.  The differential effects of stay-at-home orders on mood and sleep.

Authors:  Deirdre A Conroy; Aliya Moreira; Cathy A Goldstein
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

3.  The effects of COVID-19 stay-at-home order on sleep, health, and working patterns: a survey study of US health care workers.

Authors:  Deirdre A Conroy; Nicole L Hadler; Echelle Cho; Aliya Moreira; Chamisa MacKenzie; Leslie M Swanson; Helen J Burgess; J Todd Arnedt; Cathy A Goldstein
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

4.  Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia: A Randomized Clinical Trial.

Authors:  Michael R Irwin; Carmen Carrillo; Nina Sadeghi; Martin F Bjurstrom; Elizabeth C Breen; Richard Olmstead
Journal:  JAMA Psychiatry       Date:  2022-01-01       Impact factor: 21.596

Review 5.  We know CBT-I works, now what?

Authors:  Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis
Journal:  Fac Rev       Date:  2022-02-01

6.  Viability of an Early Sleep Intervention to Mitigate Poor Sleep and Improve Well-being in the COVID-19 Pandemic: Protocol for a Feasibility Randomized Controlled Trial.

Authors:  Kathleen Patricia O'Hora; Raquel A Osorno; Dena Sadeghi-Bahmani; Mateo Lopez; Allison Morehouse; Jane P Kim; Rachel Manber; Andrea N Goldstein-Piekarski
Journal:  JMIR Res Protoc       Date:  2022-03-14

7.  Telehealth-Delivered Cognitive Behavioral Therapy for Insomnia in Individuals with Multiple Sclerosis: A Pilot Study.

Authors:  David Turkowitch; Rebecca Ludwig; Eryen Nelson; Michelle Drerup; Catherine F Siengsukon
Journal:  Mult Scler Int       Date:  2022-03-02

8.  Delivery of Distance Counselling to Survivors of Sexual Violence: A Scoping Review of Promising and Best Practices.

Authors:  Janette Leroux; Natalie Johnston; Ashley-Anne Brown; Alanna Mihic; Denise DuBois; AnnaLise Trudell
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

9.  Sleep and mental health in pregnancy during COVID-19: A parallel process growth model.

Authors:  Lianne Tomfohr-Madsen; Charlie Rioux; Anna MacKinnon; Katherine Silang; Leslie Roos; Catherine Lebel; Gerald F Giesbrecht
Journal:  Sleep Health       Date:  2022-07-21

10.  Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial.

Authors:  J Todd Arnedt; M Elizabeth Cardoni; Deirdre A Conroy; Mandilyn Graham; Sajni Amin; Kipling M Bohnert; Andrew D Krystal; Mark A Ilgen
Journal:  Trials       Date:  2022-01-20       Impact factor: 2.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.